Inventor · disambiguated record
Anna Marie Skalka
Also filed as: SKALKA ANNA M · SKALKA ANNA MARIE
6 granted patents·4 pending applications·17 citations·filing 1988–2020
75Inventor score
Files withFOX CHASE CANCER CT4ASON BRANDON L2INSTITUTE FOR CANCER RES2CANCER RES INST1HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
10 records- 0168US9533040B2Inhibition of human immunodeficiency virus integrase reaching dimer formation utilizing single-chain variable antibodiesCANCER RES INST·Filed 2013·Granted Jan 3, 2017·2 cites·12 claims
- 0262US11389455B2Inhibitors of HIV-1 integrase multimerizationINSTITUTE FOR CANCER RES·Filed 2020·Granted Jul 19, 2022·0 cites·14 claims
- 0362US2009098548A1Modulators of enzymatic nucleic acid elements mobilizationASON BRANDON L·Filed 2008·Application pending·0 cites
- 0459US10888564B2Inhibitors of HIV-1 integrase multimerizationINSTITUTE FOR CANCER RES·Filed 2018·Granted Jan 12, 2021·0 cites·8 claims
- 0552US2011172107A1Assay for identifying agents that modulate epigenetic silencing, and agents identified therebyFOX CHASE CANCER CT·Filed 2009·Application pending·0 cites
- 0652US2006035245A1Modulators of enzymatic nucleic acid elements mobilizationASON BRANDON L·Filed 2005·Application pending·0 cites
- 0751US7736848B2Cellular targets for treatment of retroviral infectionFOX CHASE CANCER CT·Filed 2005·Granted Jun 15, 2010·0 cites·8 claims
- 0851US4957859AAntibodies for transforming ras proteinHOFFMANN LA ROCHE·Filed 1988·Granted Sep 18, 1990·13 cites·11 claims
- 0943US2011086423A1Cellular Targets for Treatment of Retroviral InfectionFOX CHASE CANCER CT·Filed 2010·Application pending·0 cites
- 1034US6150511AChimeric enzyme for promoting targeted integration of foreign DNA into a host genomeFOX CHASE CANCER CT·Filed 1995·Granted Nov 21, 2000·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Anna Marie Skalka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →